|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4709 | (2006.01) |
| A61K 31/4709 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3400942 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17735839.7 |
| Date of filing the European patent application | 2017-01-06 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/070352 |
| Date | 2017-01-06 |
| (87) | Number | WO 2017/118401 |
| Date | 2017-07-13 |
| (30) | Number | Date | Country code |
| 201610013628 | 2016-01-08 | CN |
| (72) |
WANG, Xunqiang , CN
YANG, Ling , CN
XU, Zhongnan , CN
WANG, Xiangjian , CN
GENG, Wenjun , CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ,
No. 369 Yuzhou South Rd., Lianyungang City, Jiangsu 222062,
CN
|
| (54) | USE OF QUINOLINE DERIVATIVES FOR TREATING OESOPHAGEAL CANCER AND TREATMENT METHOD, PHARMACEUTICAL COMPOSITION AND KIT THEREOF |
| USE OF QUINOLINE DERIVATIVES FOR TREATING OESOPHAGEAL CANCER AND TREATMENT METHOD, PHARMACEUTICAL COMPOSITION AND KIT THEREOF |